Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018

Status:

Topic selection

Technology type:

Medicine

Decision:

Not selected

Reason for decision:

Not eligible for Health Technology Evaluation guidance

Further information:

Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. This decision follows consideration of the product against the eligibility criteria in the NICE wide topic prioritisation manual section 7.1.3.

ID number:

12018

Project Team

Project lead

Danielle Lees

Email enquiries

If you have any queries please email [email protected]

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about prioritising our guidance topics